Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Apr 29, 2024 | 0.79 | +2.16 |
T-Mobile US | TMUS | Apr 29, 2024 | 164.25 | +0.18 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Apr 29, 2024 | 34.52 | -0.17 |
T. Rowe Price Dividend Growth ETF | TDVG | Apr 29, 2024 | 37.17 | +0.32 |
T. Rowe Price Equity Income ETF | TEQI | Apr 29, 2024 | 38.95 | +0.43 |
T. Rowe Price Group | TROW | Apr 29, 2024 | 112.08 | -1.70 |
T. Rowe Price Growth Stock ETF | TGRW | Apr 29, 2024 | 33.37 | -0.29 |
T2 Biosystems | TTOO | Apr 29, 2024 | 2.94 | +3.52 |
Taboola.com | TBLA | Apr 29, 2024 | 4.25 | +0.47 |
Tactile Systems Technology | TCMD | Apr 29, 2024 | 14.13 | -1.19 |
Taitron Components A | TAIT | Apr 29, 2024 | 3.19 | +0.63 |
Taiwan Fund | TWN | Apr 29, 2024 | 39.10 | +1.93 |
Taiwan Index MSCI Ishares | EWT | Apr 29, 2024 | 47.91 | +1.72 |
Taiwan Semiconductor Manufacturing ADR | TSM | Apr 29, 2024 | 138.50 | +0.14 |
Take-Two Interactive Software | TTWO | Apr 29, 2024 | 144.27 | -0.14 |
Takeda Pharmaceutical ADR | TAK | Apr 29, 2024 | 13.17 | +1.07 |
TAL Education Group ADR | TAL | Apr 29, 2024 | 12.66 | -5.59 |
Talis Biomedical | TLIS | Apr 29, 2024 | 9.07 | -0.77 |
Talkspace | TALK | Apr 29, 2024 | 3.09 | -0.96 |
Talos Energy | TALO | Apr 29, 2024 | 14.02 | +0.57 |
Talphera | TLPH | Apr 29, 2024 | 0.99 | 0.00 |
Tandem Diabetes Care | TNDM | Apr 29, 2024 | 37.05 | +5.14 |
Tanger | SKT | Apr 29, 2024 | 28.61 | -0.93 |
Tango Therapeutics | TNGX | Apr 29, 2024 | 7.87 | +5.78 |
Tantech | TANH | Apr 29, 2024 | 0.56 | +0.89 |
Taoping | TAOP | Apr 29, 2024 | 1.00 | +2.03 |
Tapestry | TPR | Apr 29, 2024 | 40.98 | +2.32 |
Targa Resources | TRGP | Apr 29, 2024 | 117.20 | +0.29 |
Target | TGT | Apr 29, 2024 | 163.73 | -0.61 |
Target Global Acquisition I A | TGAA | Apr 29, 2024 | 11.23 | +0.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.